{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:07:12Z","timestamp":1791317232234,"version":"4.3.1"},"reference-count":68,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2014.00040","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T19:54:23Z","timestamp":1396036463000},"source":"Crossref","is-referenced-by-count":78,"title":["New therapeutic approaches for treatment of tularaemia: a review"],"prefix":"10.3389","volume":"4","author":[{"given":"Sandrine","family":"Boisset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Caspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Sutera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Maurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,3,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1128\/AAC.05305-11","article-title":"The class A beta-lactamase FTU-1 is native to Francisella tularensis","volume":"56","author":"Antunes","year":"2012","journal-title":"Antimicrob. Agents Chemother"},{"key":"B2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1469-0691.2001.00234.x","article-title":"Treatment of tularemia with levofloxacin","volume":"7","author":"Aranda","year":"2001","journal-title":"Clin. Microbiol. Infect"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e25333","DOI":"10.1371\/journal.pone.0025333","article-title":"Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37","volume":"6","author":"Barlow","year":"2011","journal-title":"PLoS ONE"},{"key":"B4","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.4049\/jimmunol.178.7.4538","article-title":"Active suppression of the pulmonary immune response by Francisella tularensis Schu4","volume":"178","author":"Bosio","year":"2007","journal-title":"J. Immunol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7883\/yoken.JJID.2006.229","article-title":"Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses","volume":"59","author":"Celebi","year":"2006","journal-title":"Jpn. J. Infect. Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s15010-009-8193-5","article-title":"Water-borne outbreak of oropharyngeal and glandular tularemia in Georgia: investigation and follow-up","volume":"37","author":"Chitadze","year":"2009","journal-title":"Infection"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1128\/AAC.41.6.1288","article-title":"Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice","volume":"41","author":"Conley","year":"1997","journal-title":"Antimicrob. Agents Chemother"},{"issue":"26","key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00026","article-title":"Immunity to francisella","volume":"2","author":"Cowley","year":"2011","journal-title":"Front. Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/clinids\/17.6.976","article-title":"Tularemia: treatment failures with outpatient use of ceftriaxone","volume":"17","author":"Cross","year":"1993","journal-title":"Clin. Infect. Dis"},{"key":"B10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood.V78.6.1420.1420","article-title":"A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer","volume":"78","author":"Crown","year":"1991","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1128\/CVI.00636-12","article-title":"Targeting the \u00e2\u20ac\u0153cytokine storm\u00e2\u20ac\u009d for therapeutic benefit","volume":"20","author":"D'Elia","year":"2013","journal-title":"Clin. Vaccine Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3201\/eid1906.130138","article-title":"Treatment of tularemia in pregnant woman, France","volume":"19","author":"Dentan","year":"2013","journal-title":"Emerging Infect. Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.micinf.2008.10.005","article-title":"NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS","volume":"11","author":"Elkins","year":"2009","journal-title":"Microbes Infect"},{"key":"B14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1196\/annals.1409.014","article-title":"Innate and adaptive immunity to Francisella","volume":"1105","author":"Elkins","year":"2007","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"B15","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4049\/jimmunol.162.4.2291","article-title":"Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria","volume":"162","author":"Elkins","year":"1999","journal-title":"J. Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1128\/CMR.15.4.631-646.2002","article-title":"Tularemia","volume":"15","author":"Ellis","year":"2002","journal-title":"Clin. Microbiol. Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/clinids\/19.1.42","article-title":"Streptomycin and alternative agents for the treatment of tularemia: review of the literature","volume":"19","author":"Enderlin","year":"1994","journal-title":"Clin. Infect. Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00005792-198507000-00006","article-title":"Tularemia: a 30-year experience with 88 cases","volume":"64","author":"Evans","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.peptides.2013.02.024","article-title":"Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice","volume":"43","author":"Flick-Smith","year":"2013","journal-title":"Peptides"},{"key":"B20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.rvsc.2003.12.002","article-title":"In vitro susceptibility of field isolates of Francisella tularensis subsp. holarctica recovered in Spain to several antimicrobial agents","volume":"76","author":"Garcia del Blanco","year":"2004","journal-title":"Res. Vet. Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1093\/jac\/dks238","article-title":"Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species","volume":"67","author":"Georgi","year":"2012","journal-title":"J. Antimicrob. Chemother"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/jac\/dkq315","article-title":"Phenotypic and genetic characterization of macrolide resistance in Francisella tularensis subsp. holarctica biovar I","volume":"65","author":"Gestin","year":"2010","journal-title":"J. Antimicrob. Chemother"},{"key":"B23","first-page":"61","article-title":"Tularemia pneumonia","volume":"12","author":"Gill","year":"1997","journal-title":"Semin. Respir. Infect"},{"key":"B24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4049\/jimmunol.179.1.532","article-title":"Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis","volume":"179","author":"Kirimanjeswara","year":"2007","journal-title":"J. Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2013.863409","article-title":"Nanoliposome-based antibacterial drug delivery","author":"Hallaj-Nezhadi","year":"2013","journal-title":"Drug Deliv"},{"key":"B26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1517\/13543784.17.3.387","article-title":"Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections","volume":"17","author":"Hammerschlag","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3201\/eid1602.081727","article-title":"Investigating an airborne tularemia outbreak, Germany","volume":"16","author":"Hauri","year":"2010","journal-title":"Emerging Infect. Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1586\/14787210.6.2.231","article-title":"Tularemia: current diagnosis and treatment options","volume":"6","author":"Hepburn","year":"2008","journal-title":"Expert Rev. Anti Infect. Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/jac\/46.2.287","article-title":"In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals","volume":"46","author":"Ikaheimo","year":"2000","journal-title":"J. Antimicrob. Chemother"},{"key":"B30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cellimm.2010.05.005","article-title":"Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts","volume":"264","author":"Into","year":"2010","journal-title":"Cell. Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/00365540110080773","article-title":"In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis.","volume":"34","author":"Johansson","year":"2002","journal-title":"Scand. J. Infect. Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-065X.2008.00689.x","article-title":"Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis","volume":"225","author":"Kirimanjeswara","year":"2008","journal-title":"Immunol. Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6874","DOI":"10.1016\/j.vaccine.2008.09.077","article-title":"Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody","volume":"26","author":"Klimpel","year":"2008","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3109\/00365548.2013.796089","article-title":"A case of oculoglandular tularemia resistant to medical treatment","volume":"45","author":"Kosker","year":"2013","journal-title":"Scand. J. Infect. Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/vbz.2012.1065","article-title":"Prevalence of Francisella tularensis and francisella-like endosymbionts in the tick population of hungary and the genetic variability of francisella-like agents","volume":"13","author":"Kreizinger","year":"2013a","journal-title":"Vector Borne Zoonotic Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/jac\/dks399","article-title":"Antimicrobial susceptibility of Francisella tularensis subsp. holarctica strains from Hungary, Central Europe","volume":"68","author":"Kreizinger","year":"2013b","journal-title":"J. Antimicrob. Chemother"},{"key":"B37","first-page":"84","article-title":"Sensitivity to macrolide antibiotics and lincomycin in Francisella tularensis holarctica.","volume":"24","author":"Kudelina","year":"1980","journal-title":"J. Hyg. Epidemiol. Microbiol. Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1517\/13543776.17.3.267","article-title":"Vaccines and therapeutic agents for tularemia","volume":"17","author":"KuoLee","year":"2007","journal-title":"Expert Opin. Ther. Patents"},{"key":"B39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/ng1499","article-title":"The complete genome sequence of Francisella tularensis, the causative agent of tularemia","volume":"37","author":"Larsson","year":"2005","journal-title":"Nat. Genet"},{"key":"B40","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.4049\/jimmunol.180.11.7574","article-title":"Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia","volume":"180","author":"Lembo","year":"2008","journal-title":"J. Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1128\/AAC.02421-12","article-title":"Cytosporone B, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium","volume":"57","author":"Li","year":"2013","journal-title":"Antimicrob. Agents Chemother"},{"key":"B42","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1086\/520458","article-title":"Treatment of tularemia with fluoroquinolones: two cases and review","volume":"29","author":"Limaye","year":"1999","journal-title":"Clin. Infect. Dis"},{"key":"B43","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3760\/cma.j.issn.0366-6999.2010.13.021","article-title":"Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharide-induced peritonitis","volume":"123","author":"Liu","year":"2010","journal-title":"Chin. Med. J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.imlet.2007.07.006","article-title":"Generation and characterization of hybridoma antibodies for immunotherapy of tularemia","volume":"112","author":"Lu","year":"2007","journal-title":"Immunol. Lett"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1128\/AAC.44.12.3428-3431.2000","article-title":"Bactericidal activities of antibiotics against intracellular Francisella tularensis","volume":"44","author":"Maurin","year":"2000","journal-title":"Antimicrob. Agents Chemother"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/cid\/cir612","article-title":"Human tularemia in France, 2006\u00e2\u20ac\u201c2010","volume":"53","author":"Maurin","year":"2011","journal-title":"Clin. Infect. Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1600-0463.2008.00901.x","article-title":"Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia","volume":"116","author":"Meric","year":"2008","journal-title":"APMIS"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1128\/AAC.00390-10","article-title":"Bioavailability and efficacy of levofloxacin against Francisella tularensis in the common marmoset (Callithrix jacchus)","volume":"54","author":"Nelson","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"B49","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.169.7.3883","article-title":"The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses","volume":"169","author":"Scott","year":"2002","journal-title":"J. Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1128\/AAC.48.12.4513-4519.2004","article-title":"Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection","volume":"48","author":"Pammit","year":"2004","journal-title":"Antimicrob. Agents Chemother"},{"key":"B51","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/jac\/dki248","article-title":"Tigecycline","volume":"56","author":"Pankey","year":"2005","journal-title":"J. Antimicrob. Chemother"},{"key":"B52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/archinte.1987.00370020083041","article-title":"Factors associated with a poor outcome in tularemia","volume":"147","author":"Penn","year":"1987","journal-title":"Arch. Intern. Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1086\/322601","article-title":"Tularemia epidemic in northwestern Spain: clinical description and therapeutic response","volume":"33","author":"Perez-Castrillon","year":"2001","journal-title":"Clin. Infect. Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/jac\/dki359","article-title":"In vivo efficacy of fluoroquinolones against systemic tularemia infection in mice","volume":"56","author":"Piercy","year":"2005","journal-title":"J. Antimicrob. Chemother"},{"key":"B55","first-page":"156","article-title":"Galantamine effect on tularemia pathogenesis in a BALB\/c mouse model","volume":"16","author":"Pohanka","year":"2012","journal-title":"Iran. Biomed. J"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1128\/IAI.00736-09","article-title":"Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection","volume":"78","author":"Pyles","year":"2010","journal-title":"Infect. Immun"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1476-8518-8-2","article-title":"CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols","volume":"8","author":"Rozak","year":"2010","journal-title":"J. Immune Based Ther. Vaccines"},{"key":"B58","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/CVI.00362-08","article-title":"Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy","volume":"16","author":"Savitt","year":"2009","journal-title":"Clin. Vaccine Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1699-0463.1993.tb00077.x","article-title":"Susceptibility pattern of Scandinavian Francisella tularensis isolates with regard to oral and parenteral antimicrobial agents","volume":"101","author":"Scheel","year":"1993","journal-title":"APMIS"},{"key":"B60","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1371\/journal.ppat.1002587","article-title":"Immunotherapy for tularemia","volume":"4","author":"Skyberg","year":"2013","journal-title":"Virulence"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1002587","DOI":"10.1371\/journal.ppat.1002587","article-title":"Nasal Acai polysaccharides potentiate innate immunity to protect against pulmonary Francisella tularensis and Burkholderia pseudomallei Infections","volume":"8","author":"Skyberg","year":"2012","journal-title":"PLoS Pathog"},{"key":"B62","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ijantimicag.2006.02.006","article-title":"Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin","volume":"27","author":"Steward","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/jac\/dkt321","article-title":"Evolution toward high-level fluoroquinolone resistance in Francisella species","volume":"69","author":"Sutera","year":"2014","journal-title":"J. Antimicrob. Chemother"},{"key":"B64","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1016\/j.vaccine.2012.05.037","article-title":"Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia","volume":"30","author":"Sutherland","year":"2012","journal-title":"Vaccine"},{"key":"B65","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/BF01964409","article-title":"In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin","volume":"10","author":"Syrjala","year":"1991","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1196\/annals.1409.017","article-title":"New approaches to diagnosis and therapy of tularemia","volume":"1105","author":"Tarnvik","year":"2007","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijantimicag.2005.07.003","article-title":"Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains","volume":"26","author":"Tomaso","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B68","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0168-3659(03)00358-4","article-title":"Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection","volume":"92","author":"Wong","year":"2003","journal-title":"J. Control. Release"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T09:04:55Z","timestamp":1716627895000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2014.00040\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,28]]},"references-count":68,"URL":"https:\/\/doi.org\/10.3389\/fcimb.2014.00040","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,28]]}}}